Isis Initiates Clinical Trial Of CRP Drug

�Isis
Pharmaceuticals, Inc. (Nasdaq: ISIS) proclaimed it has initiated a
Phase 1 study of ISIS 353512, an antisense drug that inhibits the
production of C-reactive protein (CRP). CRP levels are frequently raised
in patients with a variety of diseases including cardiovascular disease,
Crohn's disease, rheumatoid arthritis and end-stage renal disease. The
Phase 1 sketch of ISIS 353512 is a blinded, randomized, placebo-controlled,
dose-escalation study designed to assess the safety and pharmacokinetic
profile of ISIS 353512 as well as to assess the initial effects of the drug
on baseline CRP levels in hefty volunteers. In addition, Isis is
design a blanket Phase 2 program to investigate multiple indications for
ISIS 353512.



"We consider that CRP plays an important causal role not only in
cardiovascular disease but likewise in renal and instigative diseases. Based
on our preclinical information, and the safety and pharmacological information we will
obtain from this cogitation, we plan to create a Phase 2 development plan that
evaluates several of the most scientifically and commercially attractive
indications for ISIS 353512," aforesaid Stanley Crooke, Chairman and Chief
Executive Officer of Isis. "CRP is an excellent illustration of the power of our
technology which enables us to efficiently develop drugs to any target and
to select targets that supply the most significant curative benefit in
disease areas where new treatment options are urgently needed."

ISIS 353512 Targets CRP



ISIS 353512 is an antisense dose that targets CRP. For many days, CRP
has been used as a clinical biomarker of diseases with an inflammatory
factor, such as cardiovascular disease, Crohn's disease, rheumatoid
arthritis and end-stage renal disease. Elevated levels of CRP have been
linked to coronary artery disease and a growing body of evidence from
clinical trials implicates CRP in cardiovascular disease progression.
Although CRP's active engagement in these diseases remains to be
determined, several lines of evidence support a causal role of CRP in
disease, suggesting that it may be therapeutically good to decrease
CRP levels in patients who ar at danger for coronary thrombosis events. In addition,
elevated CRP levels have been associated with a worsening of overall
outcome in conditions such as end-stage renal disease, suggesting that
lowering CRP in these patients would be good. In presymptomatic studies,
ISIS 353512 produced dramatic suppression of liver and serum CRP levels.

ABOUT ISIS PHARMACEUTICALS, INC.



Isis is exploiting its expertness in RNA to light upon and develop novel
drugs for its product line and for its partners. The Company has
successfully commercialized the world's number one antisense dose and has 18
drugs in development. Isis' dose development programs are focused on
treating cardiovascular and metabolic diseases. Isis' partners are
development antisense drugs invented by Isis to treat a wide variety of
diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary company, is
development and commercializing the Ibis T5000(TM) Biosensor System, a
revolutionary system to identify infectious organisms. Isis is a joint
owner of Regulus Therapeutics LLC, a joint speculation focused on the
discovery, development and commercialization of microRNA therapeutics. As
an innovator in RNA-based do drugs discovery and development, Isis is the owner
or exclusive licensee of over 1,D issued patents worldwide. Additional
information about Isis is available at http://www.isispharm.com.



This press out release includes forward-looking statements regarding Isis'
discovery and development of drugs for cardiovascular diseases, and the
potential of the antisense drug ISIS 353512 to treat cardiovascular, renal
and inflammatory diseases. Any command describing Isis' goals,
expectations, financial or other projections, intentions or beliefs is a
modern statement and should be considered an at-risk statement,
including those statements that are described as Isis' goals. Such
statements ar subject to certain risks and uncertainties, particularly
those inherent in the serve of discovering, developing and
commercializing drugs that ar safe and effective for use as human
therapeutics, and in the effort of building a line around such
products. Isis' forward-looking statements also involve assumptions that,
if they never happen or evidence correct, could cause its results to
differ materially from those expressed or implied by such forth looking
statements. Although Isis' forward-looking statements reflect the good
religion judgment of its management, these statements are based only on facts
and factors currently known by Isis. As a answer, you ar cautioned non to
swear on these forward-looking statements. These and other risks concerning
Isis' programs are described in additional detail in Isis' annual report on
Form 10-K for the yr ended December 31, 2007, and its quarterly report on
Form 10-Q for the quarter ended June 30, 2008, which are on file with the
SEC. Copies of these and early documents are available from the Company.



In this press waiver, unless the context requires otherwise, "Isis,"
"Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its
subsidiaries.

Isis Pharmaceuticals is a registered trademark of Isis Pharmaceuticals,
Inc. Ibis Biosciences and Ibis T5000 are trademarks of Ibis Biosciences,
Inc. Regulus Therapeutics is a trademark of Regulus Therapeutics LLC.


Isis Pharmaceuticals, Inc.
http://www.isispharm.com



More info

• Cheap drug hope for breast cancer
• Rainy weather getting people down in N.B.
• For strokes, closest hospital might not be best
• How to Tell When Leftovers Go Bad
• BRIDION(R) (sugammadex) Injection - First And Only Selective Relaxant Binding Agent - Approved In European Union

Mp3 music: Gary Stroutsos

Artist: Gary Stroutsos: mp3 download    Genre(s):  Easy Listening     Gary Stroutsos's discography:      ORU The Natural Order    Year: 1998    Tracks: 8 A musician with a multifariousness of musical influences, from Afro-Cuban to idle words, Gary Stroutsos is to the highest degree at base playing cedar tree flutes in the Native American tradition. Dedicated to Native American culture and environmentalism, his medicine has been featured in several Native American showcases and he performed for the televised Earth Day jubilation in British Columbia, Caretakers of the Earth. In 2000, he teamed up with Jonn Serrie to handout the raw historic menses unification album Hidden World. A solo effort, entitled Pacific Moon, followed in early 2001. A twelvemonth by and by he delivered two albums: Echoes of Canyon de Chelly, a collaborationism with Paul Thompson, and also Oru: The Natural Order, a collaboration with vocalists Lazaro Galarraga and Elaine Hernandez.

Sheryl Crow trades album for registered voters

Download Sea Hags

Artist: Sea Hags: mp3 download    Genre(s):  Other     Discography:      Sea Hags    Year: 1989    Tracks: 11 Sea Hags' quicksilver aliveness history redefined the artistry of self-annihilation, and the band's little carry was over virtually ahead it began -- how stone & turn over of them. Hailing from Seattle, Sea Hags were formed in 1985 by Ron Yocom (vocals, guitar), Frankie Wilsey (guitar), Chris Schlosshardt (bass), and Adam Maples (drums), wHO jointly decided to relocate to San Francisco in a bid to get under one's skin closer to their Hollywood hair metal dreams. Metallica's Kirk Hammett lententide a hand in the recording of their low gear demo, and such was its assure that after signing with Chrysalis Records, production on their eponymous 1989 debut was charged to Guns N' Roses technologist Mike Clink. Processing the sounds of '80s sleaze metallic element through the Pacific Northwest's distinctly darker and occult (and unsuspectingly pre-grunge) sonic esthetic, the album met with a great deal critical victor, just was a commercial floating-point cognitive process. Not that it mattered, since the inherently fated outfit would presently live up to their decadent image by break up under bitter circumstances (subject matter blackguard, canceled performances, etc.) in the middle of a European turn. To echo their manager's argument at the time: "There's only so far you can get with trey junkies and one alcohol-dependent." Tentative plans for a counter remained simply that, and when Schlosshardt suffered a lethal diacetylmorphine o.d. in 1991, Sea Hags were officially no more. Yokom has eluded the media centre of all time since, and though Maples was concisely rumored to be Steven Adler's renewal in GNR, it was Wilsey wHO eventually found a laconic rock & roll hereafter of sorts, changing his call to Wilsex and connexion Stephen Pearcy's Arcade.

The 4-Squares

The Streets reveal new album artwork

The Streets' Mike Skinner has revealed the

Labradford

   
Artist: Labradford

   Genre(s): 
Rock
   Instrumental
   Other
   Alternative
   Indie
   Electronic
   

---

Discography:


   
 A Stable Reference

   Year: 2002   
Tracks: 9


   
 Live Seattle

   Year: 1999   
Tracks: 6


   
 Lee's Palace, Toronto Canada

   Year: 1999   
Tracks: 1


   
 E Luxo So

   Year: 1998   
Tracks: 6


   
 Mi Media Naranja

   Year: 1997   
Tracks: 7


   
 Scenic Recovery [10'']

   Year: 1996   
Tracks: 2


   
 Scenic Recovery

   Year: 1996   
Tracks: 2


   
 Labradford

   Year: 1996   
Tracks: 7


   
 Julius [7'']

   Year: 1995   
Tracks: 2


   
 Peel Lession

   Year: 1994   
Tracks: 4


   
 Prazision [UK-Import]

   Year: 1993   
Tracks: 12


   
 Prazision Lp

   Year: 1993   
Tracks: 12

---

Consisting of bassist Robert Donne, guitarist/vocalist Mark Nelson, and Carter Brown on keyboards, Labradford are an observational ambient/post-rock mathematical group from Richmond, Virginia. Incorporating electronics as well as untraditional arrangement and production techniques, the group's soundtrack-y, effects-heavy transonic landscapes control in a vena closely allied with groups such as Experimental Audio Research, Flying Saucer Attack, and Gastr del Sol, and get earned the mathematical group high extolment among a diverse motley of different audiences. The trio have released real through and through American indies Merge and Kranky, as well as the Kiwi rock candy mark Flying Nun and Stereolab's Duophonic imprint. Though now and then incorporating vocal and rhythmic elements, the chemical group swear to the highest degree a great deal on the trailer aesthetic, mixture iteration guitar effects and long keyboard passages with snippets of barely-audible voice and motley set up objects on records like 1994's Prazision, 1995's Stable Reference, 1996's self-titled effort and 1997's Mi Media Naranja. 1999 brought the release of a novel album, E Luxo So, as well as a go with Godspeed You Black Emperor! and their Festival Of Drifting series, which besides featured appearances from Pole, Matmos and Papa M. The ultra-minimal Fixed::Context followed two years later.





Tom Waits on tour: Anything but old hat

Martin Lawrence signs with CAA

Ended 15-year relationship with UTA this month

Martin Lawrence has landed in the arms of CAA, signing with the agency for representation in all areas.


The comedian exited UTA earlier in June, ending what had been a 15-year relationship.


He is best known for his work in the massively successful "Big Momma's House" and "Bad Boys" movies as well as "Wild Hogs." More recently he starred in "Welcome Home Roscoe Jenkins" and "College Road Trip," movies that underperformed at the boxoffice.


He also headlined the hit concert films "Martin Lawrence Live: Runteldat" and "You So Crazy" and is also the principal in Runteldat Entertainment, which produces the Starz comedy showcase "Martin Lawrence Presents 1st Amendment Stand-Up," now entering its third season.


Lawrence continues to be repped by the Collective and attorney Lawrence Rose of Gang Tyre Ramer & Brown.

See Also

• Amerie - Amerie Signs With Def Jam Records
• Judge threatens reporter with arrest at trial of singer R. Kelly
• Should Mariah Carey Be Worried?
• Sex And The City - Satc Security Scare

Peter Michael Hamel and Wolfgang Hattinger

   
Artist: Peter Michael Hamel and Wolfgang Hattinger

   Genre(s): 
Electronic: Progressive
   

---

Discography:


   
 De Visione Dei

   Year: 2001   
Tracks: 5

---